🎉 We’re thrilled to be shortlisted for the MedTech 50, a selection of the most innovative medtech companies by BusinessCloud.co.uk. We need your vote to help us make the top 50. Cast your vote for Mendelian before 24 July 👇 businesscloud.co.uk/medtech-50-vot…

A new study indicates single gene therapy injection could dramatically reduce the bleeding risk faced by people with haemophilia. Promising news that could revolutionise the lives of adults living with haemophilia bbc.co.uk/news/health-62… #GeneTherapy #RareDisease

Improving Familial Hypercholesterolemia (FH) diagnosis is a key priority of the @NHS Long Term plan, but what is it and how do we find the undiagnosed? Find out in our new explainer 👉 bit.ly/3OyL7ko #RareDisease

The next five to ten years should see "cutting-edge technologies being trialled to assist clinicians in delivering high quality care... which will ultimately improve and save more lives." Our CEO, Dr Peter Fish, on what digital #primarycare should look like in the future 💬

Our CEO, Dr Peter Fish, talks to Healthcare Business International about our mission to end the diagnostic odyssey by bringing timely patient insights to primary care #RareDiseases bit.ly/3SyHfTS

How can #digitalhealth solutions play a role in advancing #healthequity? 💭 McKinsey & Company's recent article outlines how we and other digital innovators in medicine are making healthcare more equitable, from improving access to addressing unmet needs👇 mckinsey.com/industries/lif…

🔵 High cholesterol levels 🔵 Family history of early heart disease 🔵 Tendon xanthomata Do you know the symptoms of Familial Hypercholesterolemia (FH)? Find out what you need to know in our latest explainer 👉 bit.ly/3OyL7ko #RareDiseases

mendelian Well done Mendelian, you've been voted among the UK's MedTech 50! See the ranking in full: businesscloud.co.uk/medtech-50-uks…

Our CEO, Dr Peter Fish, has been featured on TechRound as part of their series of interviews with tech leaders. He talks about Mendelian's journey and what the future holds 🚀 Read it in full: techround.co.uk/interviews/a-c… #RareDiseases #DigitalHealth

1/5000 people are living with Hereditary Hemorrhagic Telangiectasia (HHT), an inherited genetic disorder that affects the blood vessels. When we analysed primary care #electronichealthrecords, which clinical feature was most frequently associated with HHT? 🤔 #RareDisease

How can #raredisease patients get a helping hand from new #medtech developments? TechHQ's recent article outlines how we're enabling doctors to identify patients who may have unrecognised rare and hard-to-diagnose diseases. techhq.com/2022/08/medtec…

We're thrilled to be working in partnership with @OxfordAHSN to evaluate the impact of using MendelScan to detect #RareDiseases across 50,000 electronic patient records and help to end the diagnostic odyssey by bringing timely patient insights to primary care

We're proud to be shortlisted as finalists for HTN Health Tech News's 'best use of digital in primary care' and 'best health tech solution of the year' awards. A proud moment for everyone in the Mendelian team 🎉 #RareDisease #HealthTech #HTNAwards

Are you attending #SCTExpo22 this week? Join our CEO, Dr Peter Fish, to hear about how we’re using SNOMED codes in UK primary care electronic health records to identify patients who may be living with undiagnosed rare and hard-to-diagnose diseases

Thank you to P4SY for sitting down with us to talk about transforming rare disease diagnoses and our involvement in the #P4SY Accelerator Programme 🚀 Read our interview in full👇 Capital Enterprise TEAM SY #DigitalHealth

👏 A powerful and promising story emphasising the importance of increasing access to genetic testing, not only for ensuring patients get the 'right' diagnosis but also reducing the risk of unnecessary treatments bbc.co.uk/news/health-63… #GeneTherapy #RareDiseases #DigitalHealth

We're thrilled to be named the winners of the ‘Best Use of Digital in Primary Care’ award at this year's #HTNAwards 🎉🚀 Thank you HTN Health Tech News! Sending our congratulations to the other winners and finalists for their fantastic work🌟

Check out our Industry view: how does the new Plan for Patients contribute to a positive digital health future? With contributions from Careology, Cinapsis, Here, Patchwork Health 💙, Spirit Health, C2-Ai, Accurx Read more:htn.co.uk/ai.php?card=7t…

📣 GPs across the UK are using our medical device software to optimise patient care pathways. With our tech solution in place, we've officially completed over 10 million patient-disease scans in 2022. Here’s what we’ve learned along the way.👇 mendelian.co/blog/5-lessons…

We're working with North East & Yorkshire Genomics and GP practices in Bradford, Northumberland and Sunderland to further demonstrate our case-finding digital technology, MendelScan, can help identify patients in primary care with undiagnosed #rarediseases. Find out more👇 ney-genomics.org.uk/our-work/rare-…